Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medtronic profit meets expectations; Covidien deal on track
Yahoo/Reuters
Tuesday, November 18, 2014 - 8:27am
tags:
Medtronic, earnings, M&A, Covidien, devices
AstraZeneca trumpets solo strength in cancer drugs post Pfizer struggle
Yahoo/Reuters
Tuesday, November 18, 2014 - 8:26am
tags:
AstraZeneca, Pfizer
Docs Were Concerned Valeant Would Acquire Allergan: Survey
WSJ Pharmalot
Monday, November 17, 2014 - 4:42pm
tags:
Allergan, Actavis, Valeant Pharmaceuticals, M&A, physicians
2 Skyrocketing Biotech Stocks In A Stalling Market
Yahoo/Benzinga
Monday, November 17, 2014 - 4:40pm
tags:
Orexigen, Achillion
Juno takes its hot CAR-T cancer tech to Wall Street in $150M IPO
Fierce Biotech
Monday, November 17, 2014 - 4:07pm
tags:
Juno Therapeutics, CAR-T, cancer, IPOs
Incyte Building Blockbuster Drug One Disease At A Time
Investors.com
Monday, November 17, 2014 - 4:05pm
tags:
Incyte, Jakafi, myelofibrosis
Long-Awaited Study Boosts Merck, Could Be Good News for Regeneron, Amgen
Barron's
Monday, November 17, 2014 - 4:03pm
tags:
Merck, Vytorin, Amgen, Regeneron
Report: Medtronic readies $10B bond flotation for Covidien deal
Mass Device
Monday, November 17, 2014 - 10:58am
tags:
Medtronic, Covidien, M&A, devices
Neuro Kinetics wins NFL grant for brain-injury detector
Mass Device
Monday, November 17, 2014 - 10:56am
tags:
Neuro Kinetics, brain injury, NFL, grants, I-Portal PAS, devices
Adexanet Alfa reverses anticoagulant effect of Eliquis in first stage of Phase 3
Seeking Alpha
Monday, November 17, 2014 - 10:55am
tags:
Eliquis, bloodthinners, Adexanet Alfa, Portola Pharmaceuticals, Pfizer, Bristol-Myers Squibb
Gilead: What About Its Pipeline?
Barron's
Monday, November 17, 2014 - 10:52am
tags:
Gilead Sciences, hepatitis C
[video]Actavis CEO: Huge commitment to R&D
CNBC
Monday, November 17, 2014 - 10:50am
tags:
Actavis, Allergan, M&A, R&D, Brent Saunders, David Pyott
Zoetis Buys Abbott’s Animal Health Assets in $255 Million Deal
Bloomberg
Monday, November 17, 2014 - 10:17am
tags:
Zoetis, Abbott Labs, animal health, M&A
Pharmaceutical giant Actavis to buy Botox maker Allergan for $66 billion in cash-and-stock
Yahoo/AP
Monday, November 17, 2014 - 10:01am
tags:
Actavis, Allergan, M&A
Valeant says can't justify matching Actavis bid for Allergan
Yahoo/Reuters
Monday, November 17, 2014 - 9:43am
tags:
Valeant Pharmaceuticals, Actavis, Allergan, M&A
Roche's Avastin Should Get The Nod From The FDA On November 19
Seeking Alpha
Monday, November 17, 2014 - 9:04am
tags:
Roche, Avastin, FDA
After Years Under Attack, Merck's Vytorin Proves Effective
Forbes
Monday, November 17, 2014 - 9:03am
tags:
Merck, Vytorin
Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer
Yahoo
Monday, November 17, 2014 - 8:55am
tags:
Actavis, Durata Therapeutics, M&A
Reckitt Benckiser to spin-off drug unit into new listing
Telegraph, UK
Monday, November 17, 2014 - 8:36am
tags:
Reckitt Benckiser, spinoffs
No safety concerns yet in trials of GSK's Ebola vaccine
Yahoo/Reuters
Monday, November 17, 2014 - 8:34am
tags:
GSK, ebola virus, clinical trials, vaccines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.